NASDAQ:VIVO - Meridian Bioscience Price Target & Analyst Ratings

$9.23
-0.38 (-3.95 %)
(As of 08/25/2019 04:00 PM ET)
Today's Range
$9.19
Now: $9.23
$9.60
50-Day Range
$9.31
MA: $11.17
$12.08
52-Week Range
$9.19
Now: $9.23
$19.84
Volume167,908 shs
Average Volume287,661 shs
Market Capitalization$394.21 million
P/E Ratio12.47
Dividend Yield2.60%
Beta0.32

Analyst Ratings

Meridian Bioscience (NASDAQ:VIVO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Meridian Bioscience in the last 12 months. Their average twelve-month price target is $11.3333, suggesting that the stock has a possible upside of 22.79%. The high price target for VIVO is $14.00 and the low price target for VIVO is $9.00. There are currently 1 sell rating and 2 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldN/A
Consensus Rating Score: 1.672.331.67N/A
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.3333$8.9333$11.3333N/A
Price Target Upside: 22.79% upside21.43% downside3.18% downsideN/A

Meridian Bioscience (NASDAQ:VIVO) Consensus Price Target History

Meridian Bioscience (NASDAQ:VIVO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/31/2019Canaccord GenuityReiterated RatingSell$9.00LowView Rating Details
5/1/2019Piper Jaffray CompaniesUpgradeUnderweight ➝ Neutral$15.00 ➝ $11.00HighView Rating Details
4/3/2019Robert W. BairdLower Price TargetNeutral$17.00 ➝ $14.00HighView Rating Details
(Data available from 8/25/2017 forward)
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel